The session will address and discuss the divide between raw accuracy metrics, typically reported for AI medical devices and actual clinical impact metrics we should be focusing on like number of increased/avoided biopsies, number of increased/missed disease detection.
Chairperson's introduction
Q&A: Numbers don’t lie, but do they misdirect?